Cargando…
Treatment Outcome of Acute Promyelocytic Leukemia with Modified Aida Protocol
We analyzed the outcome of a series of 19 newly diagnosed patients with acute promyelocytic leukemia treated with AIDA modified protocol, using mitoxantrone in place of idarubicin. Eleven patients achieved morphologic CR (58%). The remaining 8 patients had induction failure due to death during induc...
Autores principales: | Pagnano, Kátia B. Barbosa, Duarte, Gustavo de Carvalho, Lorand-Metze, Irene, Delamain, Márcia Torresan, Miranda, Eliana Cristina, De Souza, Cármino Antonio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871550/ https://www.ncbi.nlm.nih.gov/pubmed/20490274 http://dx.doi.org/10.1155/2010/672137 |
Ejemplares similares
-
Management of chronic myeloid leukemia during pregnancy: a retrospective analysis at a single center
por: Moura, Ariella Cássia de, et al.
Publicado: (2019) -
Concomitant essential thrombocythemia with JAK2 V617F mutation in a patient with chronic myeloid leukemia with major molecular response with imatinib and long-term follow-up
por: PAGNANO, KATIA BORGIA BARBOSA, et al.
Publicado: (2016) -
Monitoring of BCR-ABL levels in chronic myeloid leukemia patients treated with imatinib in the chronic phase - the importance of a major molecular response
por: Machado, Melissa Pereira, et al.
Publicado: (2011) -
Evaluation of anemia after long-term treatment with imatinib in chronic myeloid leukemia patients in chronic phase
por: Moura, Muriel Silva, et al.
Publicado: (2019) -
Using Antigen Expression of Leukemic Cells for a Fast Screening of Acute Promyelocytic Leukemia by Flow Cytometry
por: Ceni-Silva, Vitória, et al.
Publicado: (2021)